Sony and Marvel’s “Venom: The Last Dance” is struggling at the domestic box-office, but overseas it’s a whole different story. Either way, the film came in No. 1 both domestically and globally in its debut weekend.
In North America, the film is now on track to open at $51 million – well behind last week’s projections of a $65 million opening weekend. It’s also a significant drop-off from the $90 million of the previous film “Venom: Let There Be Carnage” and the $80.2 million of the first.
So it’s a failure? Well, not quite. Overseas, it’s beating expectations – taking in $124 million including a major $46 million in China, the best superhero movie debut in that market since 2019 and the best Hollywood studio film debut this year. That has raised the film’s results to a global start of $175 million against a relatively modest $120 million budget.
Sony and financiers are said to be in good shape and so won’t be losing money on this. That said, the franchise-worst B- CinemaScore from audiences suggests there’s likely not much of a future for the franchise. “Smile 2” will take second place domestically with a 59% drop to $9.
4 million followed by Vatican-set thriller “Conclave” debuting in third with $6.5 million and tying with “The Wild Robot” for that spot. The Andrew Garfield and Florence Pugh-led “We Live in Time” will round out the top spot with $4.
8 million. Source:.
